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Abstract 
The purpose of this investigation was to examine the physiological effects of 
acute BR supplementation on rugby league specific intermittent running 
performance, while also examining the effects of further supplementation on 
recovery from EIMD. It was hypothesized that BR supplementation would lead 
to improved intermittent performance and promote recovery from a rugby 
league match simulation protocol (RLMSP). An experimental, randomized, 
independent groups design was adopted, including one control group (n = 6) 
and one experimental group (n = 6). A 70 mL beetroot juice drink (BR) (~6.5 
mMol nitrate; 697.9 umol total antioxidant capacity) or control beverage was 
consumed 2.5 h prior to RLMSP performance. Participants were then required 
to ingest further beverages, twice a day, separated by 6-8 h for 48 h following 
the RLMSP. A 2-way (group [2] x time [4]) analysis of variance, independent 
and paired sample t-tests were conducted. Relative peak sprint speed was 
maintained in quartile 4 of the RLMSP in the BR group (p>0.05). There was 
no significant difference between groups for mean speed and high speed 
running (p>0.05). Blood glucose significantly decreased (p<0.05) in the BR 
group and not the control. No differences were found for oxygen consumption, 
blood lactate, heart rate and RPE (p>0.05). BR attenuated EIMD and 
promoted recovery from the RLMSP evidenced by attenuated CK 
accumulation, maintained neuromuscular function and a reduced increase in 
perceived muscular soreness (p<0.05). The findings of this study suggest that 
acute BR supplementation may enhance intermittent performance and 
attenuate EIMD following rugby league specific exercise. 
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1. Chapter 1 - Introduction 
Rugby league, played over two 40 min halves, is an intermittent contact 
sport with predominant periods of low intensity activity (walking, standing and 
jogging) interspersed with high-intensity movements (sprinting and high-speed 
running). Rugby league players, depending upon position, can complete 
distances of up to 8503 ± 631 m during a competitive game (Sykes, Twist, 
Hall, Nicholas, & Lamb, 2009; Meir, Arthur & Forrest, 1993; Gabbett, King & 
Jenkins, 2008). Due to large distances covered and intermittent nature of a 
rugby league match, both the aerobic and anaerobic energy systems are 
heavily taxed, often leading to fatigue, an example of which may be reflected 
by a decline in high-intensity running or sprint speeds during the latter stages 
of a match (Waldron, Highton, Daniels & Twist, 2013; Gabbett, 2005). This 
was evidenced by Sykes et al. (2011), where professional players locomotive 
rates at very high intensities (>19.8 km.h-1) were 3.8 m.min-1 slower in the 
fourth quartile of a match than in the first. Due to rugby leagues international 
recognition, enhancing performance and recovery from matches in order to 
facilitate success has received an abundance of attention from sports science 
practitioners in academic literature (Kempton, Sirotic & Coutts, 2014; Twist et 
al., 2012; McLellan et al., 2011; Gabbett, 2005; Gill, Beavan & Cook, 2006).  
Recent studies have investigated the ergogenic properties of nitric 
oxide (NO), found in beetroot juice (BR), while some authors have also 
speculated that BR may possess recovery benefits (Ormsbee, Lox & Arciero, 
2013; Cermak et al., 2012; Wylie et al., 2013; Lansley et al., 2012). Studies 
have reported that dietary nitrate, naturally found in BR is converted into nitrite 
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and finally NO, believed to be an ergogenic compound. NO has been a 
popular area of research in recent years with improvements found in walking, 
running, cycling, rowing and during intermittent exercise (Bailey et al., 2010; 
Bailey et al., 2009; Larsen et al., 2007; Lansley et al, 2011; Larsen et al., 
2010; Vanhatalo et al., 2010a; Wylie et al., 2012). Improvements in exercise 
performance have been attributed to various mechanisms including 
reductions in whole body oxygen consumption (∨̇O2) due to improvements in 
mitochondrial respiration, improved oxygen delivery mediated by vasodilation 
and an improved energy cost of force production through the regulation of 
calcium release (Barclay, Woledge & Curtin, 2007).  
Bailey et al. (2009) were the first to examine the ergogenic effects of 
NO supplementation. A 16% improvement in time to task failure during a 
cycling protocol was found following 6 days of NO supplementation (Bailey et 
al., 2009). Lansley et al. (2011b), adopting a more ecologically valid time-trial 
protocol found that acute (2.5 h prior) dietary nitrate supplementation resulted 
in improvements of 2.8% and 2.7% in 4 and 16.1 km cycling time trial 
performance. The findings from this study suggest that an acute bolus of BR 
can have meaningful real world improvements on performance, however, this 
study does not eludicate the effects of BR on intermittent performance. 
  Few studies have considered the effects of dietary nitrate during 
intermittent exercise. Wylie et al. (2013) found that following 2-day BR 
supplementation, performance was significantly improved in the Yo-Yo 
intermittent recovery level 1 (Yo-YoIR1) by 4.2%. The authors speculated that 
improved performance was mediated by improved glucose uptake, improved 
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potassium handling and enhanced maintenance of muscle excitability via the 
regulation of calcium release. The Yo-YoIR1 however, is not specific to the 
match demands of rugby league; a more ecologically valid test would be one 
replicating the time-motion demands of rugby league.  
Markers of exercise-induced muscle damage (EIMD), including 
increased creatine kinase, perceptual soreness and reduced muscular 
function have been found following intermittent exercise, specifically following 
professional rugby league matchplay (Twist et al., 2012; McLellan et al., 2011). 
Indeed, Twist & Sykes (2011) found significantly reduced peak knee extensor 
torque at 60 deg . s-1 for up to 48 h (reductions of ~40 N.m at 0 h, ~30 N.m at 
24 h, ~10 N.m at 48 h), significant reductions in countermovement jump 
performance at 0 and 24 h (~3 and ~2 cm, respectively) and significantly 
increased blood creatine kinase (CK) concentration at 24 h (300 U.L-1) 
following a rugby league match simulation protocol (RLMSP).  
 EIMD on a cellular level is characterized by ultrastrucural changes of 
myocytes, including z-band streaming, damaged t-tubules, sarcoplasmic 
reticulum and general sarcomere disruption, leading to impaired excitation-
contraction coupling and consequently, muscular contraction (Byrne, Twist & 
Eston, 2004). The aetiology of EIMD is not fully understood, however, EIMD 
commonly occurs following eccentric muscular contraction where high forces 
are generated with little muscle fibre recruitment, placing high mechanical 
stress on muscle sarcomeres (Byrne, Twist & Eston, 2004). EIMD also occurs 
metabolically, this form of damage is due to an exercise-induced increase in 
oxygen consumption leading to a 200-fold increase in oxygen usage in the 
mitochondria (Paternelj & Coombes, 2011). Radical oxygen species (ROS) 
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are formed when oxygen is unable to bind to hydrogen following oxidative 
phosphorylation in the mitochondria (Paternelj & Coombes, 2011). ROS 
production reportedly induces muscle cell damage through the oxidization of 
intracellular proteins and membranes, leading to protein leakage, muscle cell 
death, disturbed genetic transcription and ultimately, impaired muscle function 
(Barreiro & Hussain, 2010; Staib, Tümer & Powers, 2009; Thiebaud, 2012; 
Tee, Bosch & Lambert, 2007).  
There is evidence that antioxidant supplementation can attenuate 
EIMD by donating electrons to oxidize ROS, and/or scavenging free radical 
intermediates associated with EIMD (Paterneli & Coombes, 2011; Silva et al., 
2010;). However, studies on antioxidant supplementation have looked at 
oxidative stress markers such as CK, with little research on muscle function 
(Jakeman & Maxwell, 2007; Silva et al., 2010). In addition, the evidence 
surrounding antioxidants is less than conclusive, with some studies finding 
little to no benefits (Beaton et al., 2002) and others suggesting antioxidants 
may promote muscle damage and hinder cell adaptation following exercise 
(Childs et al., 2001; Bryant et al., 2003; Gomez-Cabrera Domenech & Vena, 
2008). 
NO is an effective vasodilator that is manufactured within the parts of 
the muscle that are receiving less, or expending more, oxygen (Bailey et al., 
2009; Bescós et al., 2012). This mechanism can help to match local blood 
flow to the parts of the muscle requiring more oxygen, providing a more 
uniform delivery of nutrient rich blood to the active skeletal muscle and (Bailey 
et al., 2009). Somewhat paradoxically however, reperfusion or enhanced 
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blood flow to damaged muscle cells could also cause an enhanced 
inflammatory response, potentially further damaging muscle architecture and 
delaying recovery (Tidball, 2005; Thiebaud, 2012). This study can contribute 
to the body of literature, indicating what mechanism has the largest influence 
on recovery up to 48 h following exercise. 
Therefore, the purpose of this investigation is to examine the 
physiological effects of acute BR supplementation on rugby league specific 
intermittent running performance, while also examining the effects of further 
supplementation on EIMD and recovery. It is hypothesized that acute BR 
supplementation will improve mean speed, sprint speeds, high-intensity 
intermittent running performance and attenuate symptoms of EIMD, including 
neuromuscular function, perceptual soreness and attenuate CK leakage in the 
48 h following exercise. 
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2. Chapter 2 - Method 
2.1. Participants 
Following approval from the Faculty of Applied and Health Sciences 
Research Ethics Committee (appendix 1), 12 healthy male participants aged 
18-25 were recruited (stature, 178.5 ± 6.03; mass, 78.6 ± 8.26; predicted 
∨̇O2MAX, 54.1 ± 6.25). Using G*Power software (Version 3.1 for Mac), a 
sample size of 12 (two groups of six) was determined as sufficient (appendix 
15). Participants were excluded from the study if they did not reach level 9 of 
the 20 m multistage fitness test (predicted maximal aerobic power >45 mL·kg
-
1
·min
-1
), representing the average aerobic fitness of a rugby league player 
(Gabbett, King & Jenkins, 2008).  
2.2. Design 
The study adopted an experimental, randomized, independent groups 
design, including one control group and one experimental group. Participants 
will be required to complete a total of 4 visits during this study (see figure 1). 
On the first testing day, participants were asked to arrive a 10:00 a.m, 
following an overnight fast. Participants allocated to the control group were 
required to consume a blackcurrant drink (16g carbohydrate, 2.5g protein) or 
a 70 mL nitrate concentrated BR shot (James White Drinks, Ipswich, UK; ~6.5 
mMol nitrate; total antioxidant capacity of 697.9 umol), 2.5 hrs prior to visit 2. 
Participants were asked to consume one concentrated BR or control 
beverage 6 h following the RLMSP. Participants were then asked to consume 
a BR or control beverage 2.5 h prior to returning to the lab on test day 3, 
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followed by an additional beverage 6-8 h later. Participants were then asked 
to consume one further beverage 2.5 h prior to returning to the lab on test day 
4 (see figure 1) in order to maintain circulating plasma nitrate (Webb et al., 
2008). Testing took place over a 10-day period with a 7-day nitrate and 
antioxidant intake restriction between visit 1 and 2.  
Participants were asked to abstain from strenuous exercise, alcohol, 
foods rich in dietary nitrate (appendix 2) including beetroot, spinach and other 
leafy greens, foods with a high antioxidant content (appendix 3) and complete 
a 10-day food diary (appendix 4). Athletes were requested to follow a diet 
incorporating a moderate-high carbohydrate intake (60–70% of energy 
consumed, ~5–7 g
.
kg-1·day-1), protein consumption of ~1.5 g
.
kg-1·day-1and fat 
ingestion of ~10–20% of their whole energy consumption (Appendix 5). 
Participants were asked to sustain an elevated carbohydrate (1 g
.
kg-1·day-1) 
and protein (0.3 g
.
kg-1·day-1) ingestion for 2 h following the RLMSP in 
accordance with the practice of elite rugby league players (Twist et al., 2012) 
(Appendix 6). In addition, participants were required to refrain from using 
antibacterial mouthwash and chewing gum during the supplementation 
periods as these have been found to eradicate the oral bacteria necessary for 
the conversion of nitrite to nitrate (Govoni, Jansson, Weitzberg & Lundberg, 
2008). 
 8 
 
 Figure 1. Schematic of study design 
2.3. Procedures 
Participants were required to complete a series of baseline 
measurements and familiarization tasks (figure 1), including one block of the 
RLMSP, during visit 1. Familiarization concluded once the participant was 
familiar with the procedures producing consistent results on the equipment 
(peak power on the isokinetic dynometer and vertical jump). Following 
familiarization the participants completed the multistage fitness test according 
to the procedure described by Léger, Mercier, Gadoury & Lambert (1988). 
  
 
 
 
 
 9 
2.4. RLMSP 
Following baseline measurements each participant was required to 
complete the RLMSP after completion of a 10 min standardized warm-up, 
performed outdoors on an artificial pitch. Humidity was 28% and temperature 
was 26.35 °C. The RLMSP was split into four quartiles lasting a total of 92.08 
min, with a 10-min passive recovery following quartile 2, replicating a half-time 
period. Participants were allowed to ingest water ad libitum at the end of each 
quartile. Participants’ locomotive speeds were dictated by an audio CD, with 
changes being signalled by a ‘‘beep’’ and an instructive voice command. The 
RLMSP-i consisted of 48 cycles and included a total of 96 sprints. The 
RLMSP-i (proved reliable to detect moderate changed in performance by 
Waldron, Highton & Twist, 2013) test was selected and repeated 4 times in 
order to replicate a worst case scenario in terms of distance covered in a 
Rubgy League match (Meir, Arthur & Forrest, 1993; Gabbett, King & Jenkins, 
2008). The test was also adapted to elicit maximal muscle damage, 
mechanically through eccentric muscle contraction due to 96 sprint 
decelerations and metabolically due to the extended exercise duration. 
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2.6. Oxygen consumption 
Participants wore a portable online gas analyser (K4 b2, Cosmed, 
Cosmed S.r.I., Rome, Italy) to measure oxygen consumption throughout the 
RLSMP-i4. To facilitate the use of the portable online gas analyser during the 
RLMSP, the contact simulation phase of the protocol was adjusted so that 
participants completed a shoulder width press-up. Due to technical errors with 
the portable online gas analyzer, oxygen consumption data was lost for 2 
participants in the control group. 
2.7. Blood measurements 
Blood glucose (Accu-Check Aviva, Roche Diagnostics, Mannheim, 
Germany) and lactate (Lactate Pro, Arkray, Kyoto, Japan) were taken via 
fingertip capillary sample, before, at the halfway stage and immediately 
following the RLMSP. Creatine kinase activity was assessed at baseline, 
immediately, 24 and 48 h following the RLMSP via fingertip capillary sample 
and analysed using a colorimetric assay procedure (Reflotron, Boehringer 
Mannheim, Germany). 
2.8. Blood pressure, height and body mass 
Following standardized procedures blood pressure of the brachial 
artery was measured on all test days, with subjects in a seated position using 
an automated sphygmomanometer (Dinamap Pro; GE Medical Systems, 
Tampa, FL). Participants’ height using a stadiometer (Wall mounted, 
Harpenden, Holtain, Crymych, Dyfed, UK) and body mass (BWB-800, Tanita, 
Tanita Corporation, Tokyo, Japan) were also measured on each test-day.  
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2.9. Isokinetic strength 
Participants performed a warm-up consisting of 5-min cycling at 100 W 
(model E834, Monark, Vardup, Sweden) before measuring isokinetic strength. 
Peak knee extensor and flexor torques were measured at 60 and 240 deg.s-1 
using the dominant limb on an isokinetic dynamometer (Biodex 3, Biodex 
Medical Systems, Shirley, NY, USA). The dominant leg was attached to the 
input arm of the dynamometer, limb mass measured by the dynamometer to 
allow for gravitational correction of peak torques and the range of motion 
determined by the researcher. After two rehearsals, participants performed 
five maximal efforts at each velocity with a 2 min rest between sets. The 
highest torque achieved at each velocity was then be used for analysis. 
2.10. Perceived muscle soreness 
Participants were asked to indicate a level of perceived muscle 
soreness for the lower limbs using a visual analogue sliding scale. The scale 
was numbered on the opposite-side; 0 indicated ‘‘no soreness on movement’’, 
5 indicated ‘‘muscles sore on movement’’, and 10 indicated that the ‘‘muscles 
were too sore to move’’. Using procedures validated by Price, McGrath, Rafli 
& Buckingham (1983), participants were asked to squat with hands on hips 
and knees shoulder-width apart to a knee joint angle of approximately 90° and 
rate their level of perceived soreness.  
2.11. Vertical jump  
Before, immediately, 24 h and 48 h following the RLMSP, participants 
were required to perform three countermovement jumps with the highest jump 
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being taken for analysis. A countermovement jump commenced with the 
participant in an upright position after which they will be asked to rapidly flex 
the knees to roughly 90° before jumping for maximal height. Flight time was 
recorded using an infrared timing system (Optojump, Microgate S.r.l, Bolzano, 
Italy) connected to a computer where flight time was calculated.  
2.12. Statistical analysis 
Data were analysed using the statistical package for social sciences for 
Mac (Version 21.0, IBM, Armonk, NY, USA). Descriptive variables were 
generated with data expressed as the mean ± standard deviations. All data 
was normally distributed with assumptions for normality assessed using the 
Shapiro-Wilk statistic (sample size <50). Between groups differences in 
oxygen consumption, mean movement speed, heart rate and blood pressure 
will be analysed using independent t-tests. Differences in creatine kinase 
activity, potassium concentration, vertical jump performance and isokinetic 
strength from baseline, immediately, 24 and 48 h and perceived muscle 
soreness immediately, 24 and 48 h following the RLMSP, were analysed 
using a 2-way (group [2] x time [4]) repeated measures (analysis of variance) 
ANOVAs. Changes in blood glucose, potassium and lactate were analysed 
using a 2-way (group [2] x time [4]) repeated measures ANOVA. Assumptions 
of sphericity were assessed using the Mauchly test of sphericity, with any 
violations adjusted by the use of the Greenhouse-Geisser correction. When 
significance effects were observed, post-hoc paired t-test analysis with a 
Bonferoni correction were performed to determine the location of differences. 
Statistical significance was set at p < 0.05 for all analysis.  
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3. Chapter 3 - Results 
3.1. Mean speed in each quartile 
ANOVA revealed no time effect (F3, 30 = 2.418, p>0.05) or group x time 
interaction (F3, 30 = 1.622, p>0.05) on mean speed in each quartile. The 
control group’s locomotor speed in each quartile was 5.56 ± 0.49, 5.63 ± 0.49, 
5.5 ± 0.48 and 5.4 ± 0.4 km.h-1 in quartiles 1, 2, 3 and 4, respectively. The BR 
groups locomotor speed in each quartile were 5.2 ± 0.53, 5.02 ± 0.48, 5.03 ± 
0.38 and 5.03 ± 0.38 km.h-1, in quartiles 1, 2, 3 and 4, respectively. 
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3.2. Mean relative sprint speed in each quartile 
There was no group x time interaction (F3, 30 = 0.638, p>0.05) on mean 
relative sprint speed in each quartile, however, a significant time effect was 
discovered (F3, 30 = 11.168, p<0.05) (figure 3).  
 
Figure 3. Mean sprint speed in each quartile relative to sprint 1. * denotes a 
significant difference to quartile 1 (p<0.05). Data expressed as means ± 
standard deviations. 
3.3. High-speed running  
There was no significant difference in high speed running between 
groups (t = 0.47, p>0.05). The control group performed high speed running for 
5.41 ± 1.95 % of the RLMSP whereas the BR group performed high speed 
running for 4.63 ± 3.18%. 
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3.4. Blood Pressure 
Systolic blood pressure was not significantly decreased, however, 
there was a significant decrease in diastolic blood pressure following BR 
supplementation (table 1).  
Table 1. Changes in blood pressure following supplementation of BR or 
placebo. 
Group Baseline 
diastolic 
blood 
pressure 
Diastolic blood 
pressure 
following 
supplementation 
Baseline 
systolic blood 
pressure 
Systolic blood 
pressure following 
supplementation 
Control 
 
 (mmHg) 
 
 
66.17 ± 3.44 66.67 ± 3.73 125.67 ± 2.56 124.5 ± 4.11 
BR  
 
(mmHg) 
 
 
121.17 ± 2.87 60.5 ± 1.1* 125.33 ± 3.76 121.17 ± 2.87 
* denotes a significant difference to baseline (p<0.05).  
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3.5. Blood glucose 
ANOVA revealed blood glucose significantly changed over time during 
the protocol (F4, 40 = 15.8, p<0.05), with reductions evident from the second 
quartile of the protocol onwards in the BR group (figure 3). No group x time 
interaction was apparent (F4, 40 = 2.33, p>0.05). 
Figure 4. Changes in blood glucose levels from baseline and each quartile of 
the RLMSP. Data presented as means ± standard deviations. * denotes a 
significant difference to baseline (p<0.05).  
3.6. Oxygen consumption 
 
Oxygen consumption throughout the protocol was not significantly 
different between the two groups (t = 1.9, p>0.05). Average oxygen 
consumption was 35.4 ± 5.3 and 30.4 ± 1.9 ml.kg.min-1 in the control and BR 
(n=6) group respectively. 
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3.7. Blood lactate 
ANOVA revealed significant changes in blood lactate over time (F1.98, 40 
= 0.4, p<0.05), however, no group x time interaction (F1.98, 40 = 8.1, p>0.05) 
was found.  
Table 2. Changes in blood lactate from baseline and after each quartile of the 
RLMSP. Data presented as means ± standard deviations. 
Group Baseline  Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Control 
(mmol/L) 
2.72 ± 2.1 5.67 ± 1.56* 4.62 ± 1.84 4.07 ± 1.73 3.78 ± 1.54 
Beetroot 
Juice 
(mmol/L) 
1.52 ± 0.54 3.55 ± 1.34* 2.45 ± 
0.98✟ 
2.33 ± 0.95 2.23 ± 0.69 
 
* denotes a significant difference to baseline (p<0.05). 
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3.8. Heart rate and RPE  
RPE was significantly different over time (F3, 30 = 13.54, p<0.05), 
however there was no interaction effect of RPE (F3, 30 =0.11, p>0.05). ANOVA 
revealed no group x time interaction (F3, 30 = 0.83, p>0.05) in heart rate, 
however a significant effect of time was discovered (F3, 30 = 5.66, p<0.05).  
Table 3. Heart rate and RPE for each quartile of the RLMSP. Data presented 
as means ± standard deviations.  
 Heart rate (beats.min-1) RPE 
 
RLMSP quartile Control Beetroot juice Control Beetroot 
juice 
Quartile 1 172.8 ± 12.2 163.6 ± 4.51 13.17 ± 1.34 13.17 ± 0.8 
Quartile 2 172.9 ± 11.1 164.2 ± 6.7 14.67 ± 1.49* 14.33 ± 1.74 
Quartile 3 164.8 ± 13.7 160.5 ± 8.04 15.5 ± 0.76* 15 ± 1.17* 
Quartile 4 164.2 ± 14.1* 159.9 ± 10.01 17.83 ± 0.69* 16.15 ± 1.62* 
* denotes significant difference to quartile 1 (p<0.05). 
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3.9. Serum CK  
ANOVA revealed a significant time effect (F3, 27 = 8.3, p<0.05) and 
group x time interaction (F3, 27  = 5.093, p<0.05). CK was significantly higher 
following the protocol in the control group compared to the BR group (figure 4).  
Figure 5. Changes in CK from baseline up to 48 h following the RLMSP. Data 
presented as means ± standard deviations. (Control group, n=5; BR group, 
n=6 at 48h) *denotes a significant difference to baseline (p<0.05). + denotes 
significant difference between groups (p<0.05). 
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3.10. Perceived muscle soreness  
A significant time effect (F3, 30 = 27.452, p<0.05) and group x time 
interaction (F3, 30 = 3.228, p<0.05) was discovered (figure 5). 
 
 
Figure 6. Changes in perceived muscular soreness up to 48 h following the 
RLMSP. * denotes a significant difference to baseline (p<0.05). + denotes a 
significant difference between groups. 
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3.11. Isokinetic strength and vertical jump performance 
 A significant group x time interaction was discovered (F3, 27 = 3.275, 
p<0.05). Peak torque was significantly reduced 24 h after the RLMSP, and 
was concomitantly lower than the BR group value at this time point. Peak 
torque in the BR group remained unchanged (figure 6). 
Figure 7. Isokinetic peak torque for knee flexors at 60 deg·s-1 at baseline and 
following the RLMSP (Control group, n=5; BR group, n=6 at 48h). + denotes a 
significant difference to control group (p<0.05). Data expressed as means ± 
standard deviations. 
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No group x time interaction (F3, 27 = 1.323, p>0.05) on peak extensor 
torque at 60 deg·s-1, however, a significant time effect (F3, 27 = 5.358, p<0.05) 
was evident. The groups had significantly different isokinetic peak torque 
immediately following the RLMSP (figure 7). 
 
Figure 8. Isokinetic peak torque for knee extensors at 60 deg·s-1 at baseline 
and following the RLMSP (Control group, n=5; BR group, n=6 at 48h). * 
denotes a significant difference to baseline (p<0.05). Data expressed as 
means ± standard deviations. 
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 No group x time interaction (F3, 27 = 2.962, p>0.05) was discovered for 
isokinetic peak torque at 240 240 deg·s-1 (figure 8). 
Figure 9. Isokinetic peak torque for knee flexors at 240 deg·s-1 at baseline and 
following the RLMSP (Control group, n=5; BR group, n=6 at 48h).  
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No group x time interaction (F3, 27 = 1.333, p>0.05) was discovered for 
peak extensor torque at 240 deg·s-1 (figure 9).
Figure 10. Isokinetic peak torque of peak knee extensor torque at 240 deg·s-1 
at baseline and following the RLMSP (Control group, n=5; BR group, n=6 at 
48h). Data expressed as means ± standard deviations. 
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Analysis revealed a significant time effect (F3, 30 = 6.4, p<0.05) and 
group x time interaction (F3, 27 = 3.263, p<0.05) on vertical jump performance 
immediately following, 24 and 48 h following the RLMSP (figure 10).  
 
Figure 11. Changes in vertical jump performance from baseline up to 48 h 
following the RLMSP (Control group, n=5; BR group, n=6 at 48 h). * denotes a 
significant difference to baseline (p<0.05). Data expressed as means ± 
standard deviations. 
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4. Chapter 4 - Discussion 
  The principle finding of this study is that NO supplementation in the 
form of BR delayed the onset of fatigue during a simulated Rugby League 
performance, evidenced by the experimental groups preservation of relative 
peak sprint speed. Moreover, BR significantly improved markers of recovery 
and attenuated muscle damage following the RLMSP. CK, vertical jump 
performance and perceptual soreness were significantly improved in following 
BR supplementation. These findings are consistent with the experimental 
hypothesis, suggesting that BR may improve RLMSP performance and 
recovery. However, contrary to prior research, there was no significant 
differences in oxygen consumption (Larsen et al., 2007; Larsen et al., 2011; 
Vanhatalo et al., 2010a). Moreover, there were no significant differences 
between groups when examining isokinetic force following the RLMSP, 
however, the control group experienced significant force losses in the knee 
extensors at 60 deg·s-1. Consistent with prior literature, BR had no significant 
effect on physiological variables including blood lactate, heart rate and blood 
glucose (Wylie et al., 2012; Wilkerson et al., 2012). However, there were 
beneficial trends in the BR group for blood glucose and isokinetic force. 
4.1. Effects of BR on RLMSP performance 
  Although not entirely dependent upon success, it has been reported 
success in intermittent sport correlates with physical fitness, the ability to 
complete high-intensity movements and the ability to resist fatigue (Gabbett, 
Kelly & Pezet, 2007; Mohr, Krustrup & Bangsbo, 2004). Wylie et al. (2013) 
found BR supplementation induced a 4.2% improvement Yo-YoIR1 
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performance; a test designed to replicate the interval and recovery periods 
that are representative of those encountered in team sports. Indeed, BR may 
also enhance rugby league specific performance in later matchplay as 
evidenced in this study. The experimental group’s sprints in quartile 4 were 
not significantly different from quartile 1, however, the control group’s sprints 
during an intermittent protocol were significantly slower (figure 3). More 
research is required to support this finding for elite players as there is 
conflicting research reporting the effects of BR supplementation in highly 
trained populations (Cermak et al., 2012; Bond et al., 2012; Christiensen et al., 
2013; Bescós et al., 2012). Furthermore, pacing strategies cannot be ruled 
out when explaining the differences in mean sprint speeds in quartile 4. 
Research on rugby league players’ locomotor behavior during matches 
discovered an “end spurt”, where running speeds increased towards the end 
of events (Waldron et al., 2013; Black & Gabbett, 2014).  
  In contrast to the experimental hypothesis, mean speed in each 
quartile and high speed running were not significantly different between 
groups, however, this may be explained by examining the supplementation 
protocol of this study. Comparable to this study, Wilkerson et al. (2012) found 
no significant effect of acute supplementation with BR (6.2 mMol NO, 2.5 h 
prior to performance) on cycling time-trial performance. Wilkerson et al. 
(2012) reported increases of plasma nitrite (a precursor to NO) concentrations 
following BR supplementation in five of their eight participants termed 
‘responders’. The increase in plasma nitrite in responders was significantly 
correlated with the difference in time-trial performance (r =-0.83, P=0.01), 
suggesting that acute supplementation may be effective only in responders to 
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NO. Furthermore, studies using longer BR supplementation protocols have 
found improvements in performance (Vanhatalo et al., 2010a; Bailey et al., 
2009). Cermak et al. (2012) reported a significant difference in 10 km time-
trial performance following chronic BR supplementation (6 days). This study 
amongst others, suggests a longer (~2-6 day) supplementation protocol may 
be more appropriate to elicit an ergogenic effect (Wylie et al., 2012; Cermak 
et al., 2012; Wilkerson et al., 2012). 
4.2. Effects of BR on physiological variables 
 Confirming the novel finding of Wylie et al. (2013), blood glucose was 
significantly reduced from baseline in the BR group during intermittent 
exercise. Due to the signaling properties of NO in skeletal muscle glucose 
uptake, it is likely glucose uptake was increased during the RLMSP following 
BR supplementation (Jentjens & Jeukendrop, 2003). Research has found that 
fatigue later in intermittent sports is a consequence of muscle glycogen and 
phosphocreatine depletion. It is feasible that the increased glucose uptake 
may have contributed to the maintenance of mean sprint speeds through the 
sparing of muscle glycogen, particularly in type II fibres (Tsintzas & Williams, 
1998; Jentjens & Jeukendrop, 2003; Mohr, Krustrup & Bangsbo, 2004).  
  A consistent finding of studies examining the effects of BR is a 
reduction in ∨̇O2 for a given workload i.e. improved exercise efficiency (Bailey 
et al., 2009; Cermak et al., 2012; Lansley et al., 2011). Upon finding no 
significant differences in ∨̇O2  between groups, this study contradicts the 
findings of prior literature. This may be due to the aforementioned limitations 
when using an acute BR supplementation. In addition, technical errors with 
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the portable gas analyser were encountered leading to two sets of ∨̇O2 data 
from the control group being lost. Indeed, the BR group’s mean ∨̇O2 was 5 L 
lower during the RLMSP, suggesting that BR may have had some effect on 
performance through an increased muscle oxygen delivery, mediated by NO 
vasodilation, thereby increasing oxidative metabolism and blunting 
intramuscular phosphocreatine decrements (Wylie et al., 2012).  
4.3. Effects of BR on muscle damage and recovery 
Similar to a prior study investigating fatigue and EIMD following a 
RLMSP, this study found significantly elevated serum CK for up to 48 h in the 
control group (Twist & Sykes, 2011). The experimental group experienced a 
significant rise in CK at 24 h following the RLMSP, however, at 24 h the 
control group demonstrated significantly higher serum CK concentrations. The 
rise in CK levels in this study, followed a similar pattern to prior research with 
peak serum CK found at 24 h, however, CK was higher than previously 
reported following a RLMSP (Twist & Sykes, 2011). This may be a result of 
the extended protocol, designed to induce further metabolic and mechanical 
EIMD (Tee, 2007). Additionally, CK appearance in the blood is reportedly 
dependent upon training status, with the most marked increases occurring in 
less trained athletes which may also explain the dissimilarities in this study 
(Broncaccio, Maffulli & Limongelli, 2007).  
  Beaton et al. (2002) discovered that antioxidant supplementation for 30 
d reduced serum CK concentration at 24 h following 240 maximal eccentric 
contractions in humans. It is understood that an elevation in intracellular levels 
of calcium ions, caused by eccentric contractions, activate proteases named 
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calpains, which cleave muscular proteins, causing secondary damage to the 
muscle cell and allow the leakage of intracellular proteins such as CK 
(Thiebaud, 2012). Furthermore, the damaged muscle induces an influx of 
macrophages and neutrophils, which further promote increases in potentially 
damaging ROS (Pizza et al., 2002; Thiebaud, 2012; Tidball, 2005). The 
RLMSP is likely to have induced large increases in damaging ROS through 
increased oxygen usage in the mitochondria and also myofibril disruption as a 
result of eccentric muscular contraction (Paternelj & Coombes, 2011). While 
in agreement with the findings of Beaton et al. (2002), a novel finding of this 
study suggests that more acute antioxidant supplementation through the 
ingestion of BR can also attenuate muscle membrane damage and the 
appearance of CK. With the reported benefits of vasodilation and 
subsequently improved reperfusion due to NO; it is feasible the BR group 
would have had a greater supply of antioxidants to donate their electron, 
thereby neutralizing ROS and subsequently attenuating EIMD in the 
experimental group (Vanhatalo et al., 2010; Paternelj & Coombes, 2011).  
 Consistent with findings following a RLMSP and rugby league match, 
perceived muscular soreness was significantly higher at all time points in both 
groups (Twist & Sykes, 2011; Twist et al., 2013). The BR group reported 
significantly greater feeling of soreness at baseline, possibly due to exercise 
prior to the study, however, following the RLMSP there was no significant 
differences between groups. Perceptual soreness has a close association 
with myofibril disruption, suggesting the antioxidants present in BR had a 
protective effect on muscular structures. (Cheung, Hume & Maxwell; Paternelj 
& Coombes, 2011). Indeed, due to the interpretation of the soreness scale, 
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exaggeration/underreporting cannot be ruled out (Nielsen et al., 2009). 
However, an attenuated increase in perceived muscular soreness may have 
positive implications for improved training quality in the days following a rugby 
league performance (Twist & Skyes, 2011). 
The pattern for isokinetic force losses in this study is inconsistent to 
prior literature, where neuromuscular function was disrupted for up to 24 h 
following a RLMSP (Twist & Sykes, 2011). Inadequate habituation to the 
dynamometer leading to a learning effect may explain this finding, however, 
the control group did experience force losses suggesting BR had an effect 
(figures 5-8). The control group’s peak knee extensor torque at 60 deg·s-1 was 
significantly lower immediately following the RLMSP whereas the BR group 
maintained isokinetic force. Additionally, the control group’s peak isokinetic 
knee flexor torque at 60 deg·s-1 was significantly lower than the BR group 
immediately following the RLMSP. The maintained flight time at all time points 
following the RLMSP in the BR group, compared to the decreases 
immediately, 24 and 48 h in control, adds further evidence to the theory of 
attenuated EIMD and maintained neuromuscular function following BR 
supplementation (figure 11). Folland, Maas & Jones (2000) discovered that 
maximal voluntary contractions in vivo, were enhanced in the presence of NO 
due improved excitation contraction coupling. Furthermore, ROS generation 
as a result of the RLMSP could have acted to inhibit E-C coupling in the 
control group by disrupting muscle ion channels and calcium release; it is 
feasible the antioxidants present in BR served to maintain neuromuscular 
function following the RLMSP by neutralizing ROS and facilitating E-C 
coupling (Shafat et al., 2004).  
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4.4. Study limitations 
Pollo, Carlino & Fabrizio, (2008) found leg extension was improved 
22.1% following the consumption of a placebo beverage. The authors 
attributed improved performance to cue signaling acting to restrict the central 
governor motor response. Due to 11 of the 12 participants correctly identifying 
their beverage, the placebo effect cannot be ruled out when examining the 
positive effects of BR in this study. A further weakness of this study is that 
plasma nitrite/NO was not measured, making identification of responders and 
non-responders impossible (Wilkerson et al., 2012). A final weakness of this 
study is a lack of control over the participants diet and prior activity. Although 
the food and activity diary method is simple and facilitates ease of adherence, 
the reliability of data can range with under-reporting and diet modifications to 
appear more socially desirable is common (Deakin, 2006). Therefore it can 
only be presumed participants adhered to the dietary regimen required in this 
study and the benefits seen were a result of BR supplementation. 
4.5. Practical applications 
The findings of this study, in conjunction with Wylie et al. (2013), 
suggest acute BR supplementation may be ergogenic for intermittent exercise. 
This may prove practically important as chronic supplementation with BR may 
become quite invasive for athletes due to adherence, the consumption of 
large boluses of BR and side effects such as beeturia (Bailey et al., 2009; 
Vanhatalo et al., 2010a). Additionally, it would appear BR supplementation 
before and up to 48 h following (~13 mMol a day; total antioxidant capacity of 
697.9 umol) rugby league specific exercie is beneficial in protecting and 
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promoting recovery from EIMD. This may have particular benefits for athletes 
who are required to recover for training and/or matches within 48h. However, 
further research is required into the effects of BR on performannce and the 
attenuation of EIMD in elite rugby league athletes. 
4.6. Conclusion 
In conclusion, acute BR supplementation facilitated the maintenance of 
peak sprint speeds during the final quartile of the RLMSP. This finding may 
have practical significance as it could allow for improved performance later in 
a match. The improvements in performance may have been induced by 
increased glucose uptake into the muscle. Finally, BR supplementation (13 
mMol a day) may act to prevent and attenuate EIMD following the RLMSP as 
evidenced by significantly reduced CK, perceived muscular soreness and 
maintained neuromuscular function. More research is required to examine the 
effects of BR supplementation in elite rugby league players before these 
findings can be applied in a professional setting.  
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Appendix 4 
Food Diary 
Name:                                         Date:     
/    /2014  
Breakfast- Food 
Consumed 
Serving 
size 
Time Cooking method Comments 
     
     
     
     
     
     
     
     
     
 
Lunch- Food Consumed Serving 
size 
Time Cooking method Comments 
     
     
     
     
     
     
     
     
     
 
Dinner- Food Consumed Serving 
size 
Time Cooking method Comments 
     
     
     
     
     
     
     
     
     
 
Snacks- Food Consumed Serving 
size 
Time Cooking method Comments 
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Appendix 5 
 
Daly dietary intake example: 
To work out the recommended dietary intake for this study please follow the 
instructions below. 
Body weight (kg) x Recommended nutrient intake (g·kg-1·day-1) = Total 
recommended nutrient intake. 
Practical example for carbohydrates: 60 x 5 = 300 g total carbohydrate, 
protein x 1.5 = 90 g total protein. 
To monitor you nutrient intake I recommend you use an online food diary 
application such as livestrong (myplate) or myfitnesspal, both downloadable 
free of charge for IPhones and Androids.  
Please see the example of a diet consisting of 300 g carbohydrate. 
Breakfast: 
40 g Quaker Oats with 300ml semi skimmed milk = 38 g carbohydrate, 11.2 g 
protein, 6.6 g fat. 
8 oz Tropicana orange juice = 26 g carbohydrate, 2 g protein. 
Lunch: 
150 g penne pasta = 132 g carbohydrate 
50 g chopped tomato = 2 g carbohydrate 
100 g skinless roast chicken breast = 1 g carbohydrate, 23 g protein. 
 
Dinner: 
450 g chinese chicken curry and rice = 83.5 g carbohydrate, 30 g protein. 
Snacks: 1 banana = 18 g carbohydrate, 1 g. 
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Appendix 6 
 
Example of a post-exercise snack following visit 2. 
Individual example: Body weight = 60 kg. 
60 kg x 0.3 g·kg-1 body weight protein = 18 g protein required. 
60 kg x 1 g·kg-1 body weight carbohydrate = 60 g carbohydrate required. 
 
Examples of snacks: 
500 ml Yazoo Chocolate Milkshake = 60 g carbohydrate, 18g protein. 
60 g grilled chicken breast & 80 g wholemeal penne pasta = 57 g 
carbohydrate, 20 g protein. 
90 g PowerBar Recovery drink with water = 63 g carbohydrate, 18 g protein. 
Please do not hesitate to ask for an example of a snack relative to your body 
weight. 
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Appendix 7 
 
 
 
Participant information sheet 
 
The effects of acute beetroot juice supplementation on the physiological 
responses of a rugby league match simulation protocol and recovery 
 
 
You are being invited to take part in a research study.  Before you decide, it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you 
wish to take part.  
 
Thank you for reading this. 
 
 
What is the purpose of the study? 
The purpose of this study is to investigate the effect of acute beetroot juice 
supplementation on the physiological responses and recovery from a Rugby 
League match simulation protocol. Beetroot juice supplementation has 
exhibited an uptake in consumption due to research showing potential 
performance enhancement during endurance, high-intensity and intermittent 
exercise. However, there is little research on team sport exercise with 
previous research in the area having neglected to examine the efficacy of 
beetroot juice supplementation on recovery.  
 
 
Why have I been chosen? 
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You have been chosen because you are a University level Rugby League 
athlete who regularly takes part in competitive matches. 
 
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you decide to take part 
you will be given this information sheet to keep and be asked to sign a 
consent form.  If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a 
decision not to take part, will not affect you in any way. 
 
 
 
 
What will happen to me if I take part? 
If you decide to take part, you will be given this information sheet to keep and 
asked to sign a consent form. You will be required to attend a total of four 
sessions; visits 1 and 2 will last no longer than 2.5 hrs and visit 3 and 4 lasting 
no longer than 1 h. You will be required to complete a 10-day food diary while 
avoiding foods high in dietary nitrate and rich in antioxidants (lists provided) 
and antibacterial mouthwash during the testing phase. You will also be 
required to abstain from alcohol in the 24 hr prior to testing. In addition, you 
will be required to have a moderate to high carbohydrate intake (60–70% of 
energy consumed, ~5–7 grams per kilogram of your body weight), a protein 
consumption of ~1.5 grams per kilogram of your body weight, and a fat 
ingestion of ~10–20% of whole energy consumption (an example is available 
on request). You will also be requested to sustain an elevated carbohydrate (1 
gram per kilogram of your body weight) and protein (0.3 grams per kilogram of 
your body weight) consumption in the 2 h following the rugby league match 
simulation protocol in visit 2 (an example is available on request). It is 
recommended you use a food diary app such as livestrong (Myplate) or 
myfitnesspal, which will provide you with your nutrient intake and content of 
the foods you eat.  
On your first visit you will be required to perform a series of baseline 
measurements including isokinetic strength, creatine kinase levels, vertical 
jump performance, multistage fitness test to exhaustion to predict your VO2max 
and a 10 minute familiarization to the Rugby League match simulation 
protocol. On your second visit you will be asked to arrive fasted overnight at 
 13 
09:00 having consumed a 70 ml Beet-it shot or placebo drink before 
completing a 92.08 min min rugby league match simulation protocol. You will 
then complete measures of isokinetic strength, creatine kinase activity, 
percieved muscular soreness, vertical jump performance as well as providing 
finger tip blood samples. You will also be required to consume a further 70 ml 
Beet-it shot, 6 hrs after the consumption of your first beetroot juice drink. You 
will be required to consume a 2 x Beet-it (separate by 6 hrs) shots a day for 2 
more days. During the final two visits, measures of isokinetic strength, 
creatine kinase activity, percieved muscular soreness and vertical jump 
performance will be retested. During the study you may experience symptoms 
of beeturia (red urine), however, this is a natural symptom following beetroot 
juice consumption and is not harmful. 
 
Testing can be flexible to suit you, however, please note that the final three 
testing sessions must be separated by 24 h each with a one-week recovery 
between visit 1 & 2. 
 
 
 
Figure 1: Schematic of study design. 
 
 
What are the possible disadvantages and risks of taking part? 
Muscle soreness following visit 2 may be a disadvantage of taking part in this 
study. Reduced range of motion is a further symptom of muscle damage 
which you may experience following visit 2, however, muscle soreness and 
reduced range of motion are common following exercise lasting usually 48-hrs. 
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You will also be required to abstain from foods high in nitrates and 
antioxidants, which may affect your existing dietary intake. 
 
 
What are the possible benefits of taking part? 
On completion of this research, participants will receive a predicted VO2max 
score. This may function as a valuable resource when planning your training 
programmes. Should the effects of beetroot juice prove beneficial to 
performance and recovery, you may confidently use beetroot juice as an 
ergogenic aid to your performance.  
 
 
What if something goes wrong? 
If you wish to complain or have any concerns about any aspect of the way you 
have been approached or treated during the course of this study, please 
contact Professor Sarah Andrew, Dean of the Faculty of Life Sciences, 
University of Chester, Parkgate Road, Chester, CH1 4BJ, 01244  513055. 
 
 
Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research 
will be kept strictly confidential so that only the researcher carrying out the 
research will have access to such information.   
 
 
 
 
 
What will happen to the results of the research study? 
The results will be written up into a dissertation for my final project of my MSc. 
Individuals who participate will not be identified in any subsequent report or 
publication. 
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Appendix 8  -   Risk Assessment Form 
Please consult a technician for advice before completing this form 
HAZARD  
(e.g. equipment / 
procedure / environment 
/ etc.) 
PERSONS 
AT RISK 
RISK OF:- CONTROLS TO BE FOLLOWED 
    
BIODEX ISOKINETIC 
DYNAMOMETER 
experimental participants joint sprains, muscle strains/tears 
pre-test health questionnaire to check for existing injuries, ensure adequate 
warm-up, ensure correct lim alignment 
BLOOD SAMPLING (CAPILLARY) 
experimental participants/ 
experimenter/technician 
blood-borne infection (e.g. HIV, hepatitis), 
bacterial infection, discomfort (repeated skin 
puncturing), fainting/dizziness/nausea 
blood testing guidelines printed in lab manuals and blood analysis area, 
experimenters trained in lab practicals and tutorials with technicians, ask 
participants if they are prone to fainting during blood tests, take first sample while 
subject seated, follow blood-testing guidelines 
CYCLE ERGOMETER WEIGHTS staff /students 
back injury from moving heavy weights 
container 
do not lift full container, push container if possible, use correct lifting technique. 
DIETARY SUPPLEMENTATION experimental participants 
Dependant on supplement. See CAFFEINE or 
GLUCOSE SUPPLEMENTATION entries or seek 
advice from study supervisor for other 
substances. 
dosage advised by supervisor, individual supplementation doses checked by 2 
people. 
EXERCISE TO EXHAUSTION experimental participants 
breathlessness, dizziness, nausea, falls, cardiac 
arrest 
pre-test health questionnaire, test not suitable for untrained participants, ensure 
subject familiarised with test ergometer, tests to be supervised by 
technician/tutor/suitably experienced PhD student. 
GAS ANALYSIS 
(douglas bag collection / 
servomex gas analyser / harvard 
experimental participants respiratory infection, claustrophobic feelings 
use sterilised mask and 3-way valve for each subject, check subject not feeling 
claustrophobic, ensure tubing attached to expired air port of 3-way valve, 
experimenter to wash hands after handling used mask/valve. 
 2 
dry gas meter) 
GPS SYSTEMS 
e.g. GPSports SPI Elite 
experimental participants 
Discomfort, bruising if participant falls onto 
body area where GPS unit is worn. 
wear supplied vests with padded pocket for GPS unit. 
HEART RATE MONITORS experimental participants skin infection wash chest belts after use 
HOLTAIN WALL-MOUNTED 
STADIOMETER  
experimental participants bangs on the head bring measuring board down slowly onto subject's head 
JUMP TESTS experimental participants muscle strains/tears 
pre-test health questionnaire, ensure adequate warm-up, supervise test and 
correct poor technique 
LACTATE PRO 
see BLOOD SAMPLING 
(CAPILLARY)   
MAXIMAL AEROBIC CAPACITY 
TESTS 
experimental participants 
breathlessness, dizziness, nausea, falls, cardiac 
arrest 
pre-test health questionnaire, test not suitable for untrained participants, ensure 
subject familiarised with test ergometer, test to be supervised by technician/tutor. 
OPTOJUMP TIMING SYSTEM experimental participants tripping over timing gates/wires 
ensure gates set wide enough for running/jumping activity, keep wires out of the 
way or mark with cones  
OXYCON ONLINE GAS ANALYSER 
experimental participants/ 
experimenter 
respiratory infection, claustrophobic feelings 
use sterilised mask and turbine for each subject, check subject not feeling 
claustrophobic, experimenter to wash hands after handling used mask/turbine 
RUNNING TESTS (in the field) / 
MULTI-STAGE FITNESS TEST 
(BLEEP TEST) 
experimental participants 
cardiac arrest in at-risk participants, muscle 
strains, joint sprains 
pre-test health questionnaire, test suitable for young/fit/healthy participants, 
ensure running surface is suitable and participants have enough space to complete 
test without colliding. 
SPHYGMOMANOMETER & 
STETHOSCOPE 
experimental participants/ 
experimenter 
discomfort from over-inflated cuff, ear 
infection from use of stethoscope 
inflate to 160/170mmHg for healthy participants, reduce cuff pressure as quickly 
as possible once reading taken, clean stethoscope earpieces with alcohol wipes 
and allow to dry before use. 
STABILOMETER (BIODEX) experimental participants 
soft tissue injuries / bone breaks from falls (in 
some participants) 
supervision by technician / tutor / post-graduate student for 
elderly/infirm/balance-impaired participants 
 3 
ARTIFICIAL 3G PLAYING 
SURFACE 
Experimental participants/ 
experimenter 
Slips, trips, hard surface (if iced over) 
New Surface layed October 2011. Pitch is inspected before every training session 
and every weekday morning by Sport and Rec staff/ Grounds and Gardens staff. 
Users are aware to report any damage to Sport and Rec staff. The pitch is brushed 
weekly. If the weather has hardened the surface, users will be informed that the 
pitch is unplayable 
FOOTWEAR FOR ARTIFICIAL 3G 
PLAYING SURFACE 
Participants Trips, slips, sprains 
Unable to turn as well in long length stud/ blades and they are therefore banned. 
Moulded studs or AstroTurf specific shoes recommended 
JAMES WHITE BEET IT SPORTS 
SHOT 
Experiental participants. Beeturia (red urine). 
Beeturia poses no risk the to health of participants, nonetheless participants will 
be warned they may experience symptoms of beeturia such as red urine during 
the supplementation period. 
 
Experimenter 
Signature 
  Technician 
Signature 
  Date  
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Appendix 9  
INFORMED CONSENT FORM 
 
 
Title of Project: The effects of acute beetroot juice supplementation on the 
physiological responses of a rugby league match simulation protocol and 
recovery. 
 
Name of Researcher: Casey Walker 
 
Please tick the box if you agree with the statement:  
 
I confirm that I have read and understood the participant 
information sheet for the above-named study, and have had the 
opportunity to ask the lead researcher any questions.   
    
 
I understand that my participation is voluntary, and that I am free to 
withdraw from participating in the study at any time, without giving 
any reason and without my rights being affected.  
 
I agree to take part in the above study. 
 
Name of Participant   Date    Signature  
 
 
 
Name of Researcher    Date    Signature  
 
(1 for participant; 1 for researcher) 
 
 2 
PRE-TEST HEALTH QUESTIONNAIRE 
 
(PLEASE NOTE THAT THIS INFORMATION WILL BE CONFIDENTIAL) 
 
Name:…………………………….  DOB:…………….. Age:………… 
 
 
The effects of acute beetroot juice supplementation on the physiological 
responses of a rugby league match simulation protocol and recovery. 
 
Please answer these questions truthfully and completely. The purpose of this 
questionnaire is to ensure that you are fit and healthy enough to participate in this 
laboratory practical/research project. 
 
Yes No 
1. Have you in the past suffered from a serious illness or accident.   
If Yes, please provide details 
 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………… 
 
Yes No 
2. Have you consulted your doctor the last 6 months      
If Yes, please provide details 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
……………………………… 
 
3. Do you suffer, or have you suffered from: 
                                                           Yes     No 
 
Asthma                                                    
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Diabetes            
Bronchitis             
Epilepsy          
   
High blood pressure             
Yes No 
4. Is there any history of heart disease in your family        
 
Yes No 
5. Are you suffering from any infectious skin diseases, sores,            
blood wounds, or infections i.e., Hepatitis B, HIV, etc.?                   
If Yes, please provide brief details 
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
Yes No 
6. Are you currently taking any medication          
If Yes, please provide details 
 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
 
 
Yes No 
7. Are you suffering from a disease that inhibits the sweating process    
 
Yes No 
8. Is there anything to your knowledge that may prevent you from     
participating in the testing that has been outlined to you? 
If Yes, please provide details 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
Your Recent Condition 
          Yes No 
 Have you eaten in the last 2 hours?        
 4 
If Yes, please provide details 
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
 Have you consumed alcohol in the last 24hr       
 Evaluate your diet over the last two days.  Poor Average Good  Excellent 
 Have you had any kind of illness or infection in the last 2 weeks     
 Have you exercised in the last 2 days?                                                               
If Yes, please describe below   
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
Persons will not be permitted to take part in any experimental testing if they: 
 have a known history of medical disorders (i.e. hypertension, heart or lung 
disease) 
 have a fever, suffer from fainting or dizzy spells 
 are currently unable to train because of a joint or muscle injury 
 have had any thermoregulatory disorder 
 have gastrointestinal disorder  
 have a history of infectious diseases (i.e. HIV or Hepatitis B) 
 have, if pertinent to the study, a known history of rectal bleeding, anal fissures, 
haemorrhoids or  any other similar rectal disorder. 
 
My responses to the above questions are true to the best of my knowledge and I am 
assured that they will be held in the strictest confidence. 
 
Name: (Participant)………………………………………… Date:…………………. 
 
Signed (Participant): ……………………………………….  
     
Name: (Researcher)………………………………………… Date:…………………. 
 
Signed (Researcher): ………………………………………. 
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Appendix 15 
G*Power calculation. 
A moderate effect size of 0.6 was selected with a power of 80% and 
significance level of 0.05. 
 
